Your browser doesn't support javascript.
loading
High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
Romaguera, Jorge E; Fayad, Luis; Rodriguez, Maria A; Broglio, Kristine R; Hagemeister, Frederick B; Pro, Barbara; McLaughlin, Peter; Younes, Anas; Samaniego, Felipe; Goy, Andre; Sarris, Andreas H; Dang, Nam H; Wang, Michael; Beasley, Virginia; Medeiros, L Jeffrey; Katz, Ruth L; Gagneja, Harish; Samuels, Barry I; Smith, Terry L; Cabanillas, Fernando F.
Afiliação
  • Romaguera JE; Department of Lymphoma, Unit 429, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. jromague@mdanderson.org
J Clin Oncol ; 23(28): 7013-23, 2005 Oct 01.
Article em En | MEDLINE | ID: mdl-16145068
Assuntos
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2005 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2005 Tipo de documento: Article